EYLEA HD
These highlights do not include all the information needed to use EYLEA HD safely and effectively. See full prescribing information for EYLEA HD. EYLEA HD (aflibercept) injection, for intravitreal use Initial U.S. Approval: 2011
86d8848b-111b-4da9-8957-7cccef1b8f66
HUMAN PRESCRIPTION DRUG LABEL
Dec 14, 2023
Regeneron Pharmaceuticals, Inc
DUNS: 194873139
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
aflibercept
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
aflibercept
Product Details
FDA regulatory identification and product classification information